Literature DB >> 27217682

Locally Advanced Askin's Tumour in a Child-a Rare Case Report and Review of the Literature.

L Purnima Devi1, Ritesh Kumar1, Jyoti Prasad Kalita2, Yookarin Khonglah3, Akash Handique4.   

Abstract

Askin's tumor is a primitive neuroectodermal tumor (PNET) developing from the soft tissues of the chest wall and mainly occur in children and adolescents. The management approach is complex and requires a multidisciplinary team. We report a case of locally advanced Askin's tumour in a child because of its rarity and also to highlight the importance of keeping the possibility of PNET tumours in mind while dealing with cases of chest wall tumour in children.

Entities:  

Keywords:  Askin’s tumour; Primitive neuroectodermal tumour; Thoracopulmonary region

Year:  2015        PMID： 27217682      PMCID： PMC4856669          DOI： 10.1007/s13193-015-0422-z

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  9 in total

1.  Preoperative chemotherapy is essential for conservative surgery of Askin tumors.

Authors:  G Veronesi; L Spaggiari; T De Pas; P G Solli; F De Braud; G P Catalano; G Curigliano; F Leo; U Pastorino
Journal:  J Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 5.209

2.  Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients.

Authors:  H Jürgens; V Bier; D Harms; J Beck; W Brandeis; G Etspüler; H Gadner; D Schmidt; J Treuner; K Winkler
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

3.  Preresection chemotherapy improves survival for children with Askin tumors.

Authors:  R S Sawin; E U Conrad; J R Park; J H Waldhausen
Journal:  Arch Surg       Date:  1996-08

4.  Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.

Authors:  E H Baldini; G D Demetri; C D Fletcher; J Foran; K C Marcus; S Singer
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

5.  Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis.

Authors:  F B Askin; J Rosai; R K Sibley; L P Dehner; W H McAlister
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

6.  Primitive neuroectodermal tumors of the chest wall (Askin tumors): CT and MR findings.

Authors:  H T Winer-Muram; W M Kauffman; S A Gronemeyer; S G Jennings
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

Review 7.  Management of tumors of the chest wall in childhood: a review.

Authors:  Hendrik van den Berg; Rick R van Rijn; Johannes Hm Merks
Journal:  J Pediatr Hematol Oncol       Date:  2008-03       Impact factor: 1.289

8.  Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region ("Askin tumor").

Authors:  R I Linnoila; M Tsokos; T J Triche; P J Marangos; R S Chandra
Journal:  Am J Surg Pathol       Date:  1986-02       Impact factor: 6.394

9.  Malignant neuroectodermal tumour of the chest wall (Askin tumour): CT and MR findings in eight patients.

Authors:  J M Sabaté; T Franquet; J A Parellada; J M Monill; E Oliva
Journal:  Clin Radiol       Date:  1994-09       Impact factor: 2.350
  9 in total
  2 in total

1.  Interdisciplinary Radical "En-Bloc" Resection of Ewing Sarcoma of the Chest Wall and Simultaneous Chest Wall Repair Achieves Excellent Long-Term Survival in Children and Adolescents.

Authors:  Alireza Basharkhah; Herwig Lackner; Anna Karastaneva; Marko Bergovec; Stephan Spendel; Christoph Castellani; Erich Sorantin; Martin Benesch; Bernadette Liegl-Atzwanger; Freyja-Maria Smolle-Jüttner; Christian Urban; Michael Höllwarth; Georg Singer; Holger Till
Journal:  Front Pediatr       Date:  2021-03-15       Impact factor: 3.418

2.  Multimodal treatment of pediatric patients with Askin's tumors: our experience.

Authors:  Silvia Triarico; Giorgio Attinà; Palma Maurizi; Stefano Mastrangelo; Lorenzo Nanni; Vito Briganti; Elisa Meacci; Stefano Margaritora; Mario Balducci; Antonio Ruggiero
Journal:  World J Surg Oncol       Date:  2018-07-13       Impact factor: 2.754
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.